Suraksha Diagnostics is a leading diagnostic center committed to providing accurate and reliable medical testing services with advanced technology and expert healthcare professionals. Suraksha Diagnostic Limited operates an extensive diagnostic network, comprising 13 Hub centres, 8 satellite Labs, 24 small centres, 11 medium centres, 4 PPP centres and 187 sample collection centres.
Nuvama Wealth Management Ltd has successfully closed a transaction of INR 8,463 mn (EUR 96 mn) as the BRLM to Suraksha Diagnostics on IPO issue. Nuvama engaged marquee global and domestic investors across FIIs, DIIs, mutual funds and family offices and played a key role in the IPO by converting key marquee long-only investors driving the deal momentum & helping set pricing benchmark. Nuvama pushed the story aggressively through our distribution channel to ensure participation from HNI & Retail category.
Advised in the sale of
Suraksha Diagnostic Limited
to